Literature DB >> 7472519

A single histidine residue is essential for zinc inhibition of GABA rho 1 receptors.

T L Wang1, A Hackam, W B Guggino, G R Cutting.   

Abstract

The GABA rho 1 subunit, cloned from a human retina library, can form homooligomeric receptors with properties similar to GABAc receptors characterized in retinal cells. The divalent cation Zn2+, abundant in the CNS and retina, was found to inhibit GABA rho 1 receptors in a voltage-independent manner. Varying the extracellular pH from 7.4 to 5.6 significantly reduced this inhibitory effect. This pH profile suggested that one or more histidine residues might play a role in the interaction between Zn2+ and the GABA rho 1 receptor. Site-directed mutagenesis revealed that a single histidine residue (His 156) in the putative extracellular domain of rho 1 was critical for Zn2+ sensitivity. Substitution of this amino acid with tyrosine (H156Y) created a functional GABA receptor with agonist and channel properties indistinguishable from wildtype. However, the H156Y mutant was insensitive to Zn2+, even at concentrations as high as 1 mM. Mutation to aspartic acid, an amino acid that can interact with Zn2+ in other proteins, preserved sensitivity to Zn2+ but abolished the pH-dependent effect. This histidine residue is also involved in Ni2+ and Cd2+ interaction since the H156Y mutation completely suppressed the inhibition effects of these two cations. These data demonstrate that an extracellular histidine residue is critical for transition metal cation sensitivity of GABA rho 1 receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7472519      PMCID: PMC6578093     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  26 in total

1.  Two gamma2L subunit domains confer low Zn2+ sensitivity to ternary GABA(A) receptors.

Authors:  N Nagaya; R L Macdonald
Journal:  J Physiol       Date:  2001-04-01       Impact factor: 5.182

2.  Kinetic and mutational analysis of Zn2+ modulation of recombinant human inhibitory glycine receptors.

Authors:  B Laube; J Kuhse; H Betz
Journal:  J Physiol       Date:  2000-01-15       Impact factor: 5.182

Review 3.  Zinc-permeable ion channels: effects on intracellular zinc dynamics and potential physiological/pathophysiological significance.

Authors:  Koichi Inoue; Zaven O'Bryant; Zhi-Gang Xiong
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 4.  Inhibition of P2X(7) receptors by divalent cations: old action and new insight.

Authors:  Lin-Hua Jiang
Journal:  Eur Biophys J       Date:  2008-04-15       Impact factor: 1.733

5.  Allosteric modulation of retinal GABA receptors by ascorbic acid.

Authors:  Cecilia I Calero; Evan Vickers; Gustavo Moraga Cid; Luis G Aguayo; Henrique von Gersdorff; Daniel J Calvo
Journal:  J Neurosci       Date:  2011-06-29       Impact factor: 6.167

Review 6.  GABA-ρ receptors: distinctive functions and molecular pharmacology.

Authors:  Moawiah M Naffaa; Sandy Hung; Mary Chebib; Graham A R Johnston; Jane R Hanrahan
Journal:  Br J Pharmacol       Date:  2017-04-12       Impact factor: 8.739

Review 7.  Conditionally and transiently disordered proteins: awakening cryptic disorder to regulate protein function.

Authors:  Ursula Jakob; Richard Kriwacki; Vladimir N Uversky
Journal:  Chem Rev       Date:  2014-02-06       Impact factor: 60.622

8.  Maintenance of Melanocyte Stem Cell Quiescence by GABA-A Signaling in Larval Zebrafish.

Authors:  James R Allen; James B Skeath; Stephen L Johnson
Journal:  Genetics       Date:  2019-08-23       Impact factor: 4.562

9.  The role of histidine residues in modulation of the rat P2X(2) purinoceptor by zinc and pH.

Authors:  J Dylan Clyne; Lisa D LaPointe; Richard I Hume
Journal:  J Physiol       Date:  2002-03-01       Impact factor: 5.182

10.  Effects of Zn2+ on wild and mutant neuronal alpha7 nicotinic receptors.

Authors:  E Palma; L Maggi; R Miledi; F Eusebi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.